Yukinori Nakamura Masafumi Matsuguma Yoshihiro Tokunaga Kaoru Yamamoto Mayumi Tanaka Yoshinori Tanaka Toshiaki Yujiri Yukio Tanizawa
10.2169/internalmedicine.56.7808
Intern Med
2017;56(10):1199-1202.
behçet's disease acute myeloid leukemia allogeneic hematopoietic stem cell transplantation azacitidine tacrolimus
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28502936/
Azacitidine / therapeutic use Behcet Syndrome / complications Behcet Syndrome / drug therapy Hematopoietic Stem Cell Transplantation Leukemia, Myeloid, Acute / drug therapy Myelodysplastic Syndromes / drug therapy Tacrolimus / therapeutic use
Azacitidine / therapeutic use Behcet Syndrome / complications Behcet Syndrome / drug therapy Hematopoietic Stem Cell Transplantation Leukemia, Myeloid, Acute / drug therapy Myelodysplastic Syndromes / drug therapy Tacrolimus / therapeutic use Case Reports Adult Antimetabolites, Antineoplastic / therapeutic use Asian People Humans Immunosuppressive Agents / therapeutic use Leukemia, Myeloid, Acute / etiology Male Myelodysplastic Syndromes / etiology Remission Induction Transplantation, Homologous Treatment Outcome Antimetabolites, Antineoplastic Immunosuppressive Agents Azacitidine Tacrolimus
PMC5491816
28502936
Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation
2017